Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Medicine
Metadata
Title
C-myc as a predictive marker for chemotherapy in metastatic breast cancer
Authors
Nataša Todorović-Raković
Zora Nešković-Konstantinović
Dragica Nikolić-Vukosavljević
Publication date
01-12-2012
Publisher
Springer Milan
Published in
Clinical and Experimental Medicine / Issue 4/2012
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-011-0169-y

Other articles of this Issue 4/2012

Clinical and Experimental Medicine 4/2012 Go to the issue

Original Article

Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes

Original Article

Tirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primates

Original Article

Establishment of an experimental method for detecting circulating miRNAs in BDL mice

Original Article

Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats

Original Article

Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis

Original Article

Recombinant human interferon gamma (Gamma Immunex) in treatment of atopic dermatitis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits